NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.250
+0.020 (1.63%)
At close: Nov 5, 2024, 4:00 PM
1.320
+0.070 (5.60%)
After-hours: Nov 5, 2024, 6:05 PM EST
NeuroSense Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -9.8 | -10.11 | -10.49 | -3.22 | -2.83 | -1.22 |
| Depreciation & Amortization | 0.02 | 0.02 | 0.01 | 0 | 0 | - |
| Loss (Gain) From Sale of Assets | - | - | - | 0.01 | - | - |
| Stock-Based Compensation | 0.82 | 1.54 | 1.73 | 1.22 | 2.06 | 0.61 |
| Other Operating Activities | -1.81 | -1.72 | 0.04 | 0.18 | -0 | - |
| Change in Accounts Receivable | 0.04 | - | - | - | -0.01 | -0 |
| Change in Accounts Payable | 0.39 | 0.96 | 0.46 | -0.02 | 0.03 | 0.02 |
| Change in Other Net Operating Assets | 0.14 | 0.95 | 0.64 | 0.29 | 0.05 | 0.01 |
| Operating Cash Flow | -10.2 | -8.35 | -7.62 | -1.54 | -0.7 | -0.58 |
| Capital Expenditures | -0.01 | -0.03 | -0.07 | -0.02 | -0.01 | -0.01 |
| Investment in Securities | - | 3.5 | -3.5 | - | - | - |
| Other Investing Activities | 0 | -0 | -0.02 | - | - | -0.02 |
| Investing Cash Flow | -0 | 3.47 | -3.59 | -0.02 | -0.01 | -0.03 |
| Short-Term Debt Repaid | - | - | - | - | - | -0 |
| Total Debt Repaid | - | - | - | - | - | -0 |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0 |
| Issuance of Common Stock | 4.32 | 3.98 | 3.87 | 11.9 | 0.51 | 1.42 |
| Other Financing Activities | - | - | -0.1 | - | - | - |
| Financing Cash Flow | 4.32 | 3.98 | 3.77 | 11.9 | 0.51 | 1.42 |
| Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0.09 | 0.02 | - | - |
| Net Cash Flow | -5.88 | -0.9 | -7.52 | 10.36 | -0.2 | 0.81 |
| Free Cash Flow | -10.21 | -8.38 | -7.69 | -1.56 | -0.7 | -0.59 |
| Free Cash Flow Per Share | -0.63 | -0.61 | -0.67 | -0.25 | -0.13 | -0.13 |
| Levered Free Cash Flow | -6.63 | -4.26 | -3.8 | -0.47 | 0.28 | - |
| Unlevered Free Cash Flow | -6.61 | -4.26 | -3.8 | -0.47 | 0.28 | - |
| Change in Net Working Capital | -0.56 | -1.74 | -1.12 | -0.2 | -0.03 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.